The FDA has approved Exdensur for add-on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in patients aged 12 and older.

The FDA has approved GSK’s Exdensur (depemokimab-ulaa) as an add-on maintenance therapy for adolescents and adults with severe asthma characterized by an eosinophilic phenotype. 1 ...

The parents of a 13-year-old girl who died after an asthma attack led to a cardiac arrest have said they fear "other families ...

HEAVY RAINFALL which may lead to FLASH FLOODING is forecast to continue for parts of Gulf Country, Northern Goldfields and Upper Flinders, North West and Central West Forecast Districts today.

All government hospitals are on Code White Alert for the most common reasons for visiting the emergency room during the ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung ...

As with any medicine, the MHRA will keep the safety and effectiveness of depemokimab under close review. The Medicines and Healthcare products ...

President Trump announced landmark drug pricing agreements with nine pharmaceutical companies and the launch of TrumpRx.gov, ...

Government agencies on Friday committed to a coordinated implementation of their respective safety measures to ensure that ...

The storm system that brought dangerous rainfall and strong winds to Southern California will bring showers to Arizona on ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...

ALBANY, N.Y. (NEWS10)—Making asthma inhalers more affordable— new legislation signed by Governor Hochul will eliminate out of pocket costs for the lifesaving medication. “It should not cost so much to ...